Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
5(71.4%)
Phase 1
2(28.6%)
7Total
Phase 2(5)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT04011020Phase 2Recruiting

Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes

Role: lead

NCT04011748Phase 2Unknown

Clinical Application of Stem Cell Educator Therapy in Alopecia Areata

Role: lead

NCT04299152Phase 2Unknown

Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19

Role: lead

NCT01350219Phase 2Unknown

Stem Cell Educator Therapy in Type 1 Diabetes

Role: lead

NCT01996228Phase 1Unknown

Reversal of Type 1 Diabetes in Children by Stem Cell Educator Therapy

Role: lead

NCT03390231Phase 2Unknown

Stem Cell Educator Therapy in Diabetes

Role: lead

NCT01673789Phase 1Unknown

Stem Cell Educator Therapy in Alopecia Areata

Role: lead

All 7 trials loaded